Additionally, the involvement of different types of mutations makes the pathology of GBM more complex, such as p53 deletion, upregulation of VEGF (vascular endothelial growth factor), EGFR, MDM2, and MGMT (O(6)-methylguanine-DNA methyltransferase) [26]. This evidence concerns the gene VEGFA and glioblastoma.